Clarification regarding the delayed submission of proceedings of Annual General Meeting.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Rekvina Laboratories held its 37th Annual General Meeting on September 26, 2025, at 2:30 PM in Vadodara, Gujarat. The meeting was attended by 16 members representing 2,904,831 equity shares (48.19% of total shareholding), confirming quorum. Three agenda items were transacted: (1) adoption of audited financial statements for FY ended March 31, 2025, (2) re-appointment of Mrs. Ilaben Pathak as Director (retiring by rotation), and (3) appointment of a Secretarial Auditor for five years. The Chairman confirmed the Auditor's Report contained no qualifications, observations, or adverse remarks. The meeting concluded at 3:30 PM. The company separately apologized to BSE for delayed submission of AGM proceedings, citing inadvertent technical uploading issues, and assured future compliance.
This is primarily a procedural compliance filing with no material impact on shareholders. The clean auditor's report and routine agenda items (financial approval, director re-appointment, auditor appointment) signal normal business operations. The delayed filing of AGM proceedings and BSE's query raise a minor governance red flag worth monitoring, though the company attributed it to technical glitches.